| 000 | 01410 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518005906.0 | ||
| 264 | 0 | _c20190416 | |
| 008 | 201904s 0 0 fre d | ||
| 022 | _a2468-7189 | ||
| 024 | 7 |
_a10.1016/j.gofs.2018.10.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLambert, M | |
| 245 | 0 | 0 |
_a[Contraception for women after 40: CNGOF Contraception Guidelines]. _h[electronic resource] |
| 260 |
_bGynecologie, obstetrique, fertilite & senologie _c12 2018 |
||
| 300 |
_a865-872 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Practice Guideline; Systematic Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aContraception _xadverse effects |
| 650 | 0 | 4 | _aContraceptives, Oral, Combined |
| 650 | 0 | 4 | _aContraceptives, Oral, Hormonal |
| 650 | 0 | 4 | _aDrug Implants |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertility |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntrauterine Devices, Copper |
| 650 | 0 | 4 | _aMetabolic Diseases |
| 650 | 0 | 4 | _aPerimenopause |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aProgestins _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aVascular Diseases |
| 700 | 1 | _aBegon, E | |
| 700 | 1 | _aHocké, C | |
| 773 | 0 |
_tGynecologie, obstetrique, fertilite & senologie _gvol. 46 _gno. 12 _gp. 865-872 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.gofs.2018.10.008 _zAvailable from publisher's website |
| 999 |
_c29040407 _d29040407 |
||